Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fagugli, R. M.
Right arrow Articles by Buoncristiani, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagugli, R. M.
Right arrow Articles by Buoncristiani, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 2332-2338
© 2003 European Renal Association-European Dialysis and Transplant Association


Original Article

Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients

Riccardo Maria Fagugli1, Paolo Pasini2, Giuseppe Quintaliani1, Franca Pasticci1, Giovanni Ciao1, Beatrice Cicconi1, Daniela Ricciardi1, Paola Vittoria Santirosi1, Emanuela Buoncristiani1, Francesca Timio1, Fabrizio Valente1 and Umberto Buoncristiani1

1Department of Nephrology-Dialysis and 2Department of Cardiology, Silvestrini Hospital, Perugia, Italy

Correspondence and offprint requests to: Riccardo Maria Fagugli, MD, S. C. Nefrologia e Dialisi, Ospedale Silvestrini, Azienda Ospedaliera di Perugia, S. Andrea delle Fratte, 06100 Perugia, Italy. Email: rmfag{at}tin.it

Background. Hypertension and left ventricular hypertrophy (LVH) are present in the majority of patients undergoing haemodialysis (HD). These two pathologies persist after dialysis onset, and pharmacological therapy is often required for adequate control of blood pressure (BP). Although fluid overload is a determinant of hypertension, clinical assessment of this parameter remains difficult and unsatisfactory. Bioimpedance analysis (BIA) spectroscopy and the relative determination of extracellular water (ECW%) may provide a simple and inexpensive tool for investigating fluid overload. We studied 110 patients on thrice-weekly HD to determine whether ECW body content correlates with hypertension and LVH in this patient population.

Methods. Hypertension was determined according to the WHO criteria (office BP >= 140/90 and/or the use of antihypertensive therapy). Twenty-four hour BP monitoring and echocardiography were performed on midweek inter-HD days. Blood chemistries, dialysis dose (spKt/V) and bioimpedance were analysed on midweek HD days.

Results. Hypertension was present in 74.5% of patients. There were no differences for age, spKt/V, haemoglobin, serum creatinine and residual renal function between normotensive and hypertensive patients. Twenty-four hour systolic BP (SBP), 24 h diastolic BP and 24 h pulse pressure were higher in hypertensive patients, in spite of antihypertensive therapy. LVH was present in 61.8% of patients. BIA revealed that ECW% was increased in LVH+ patients (LVH+ = 47.5 ± 7.9%, LVH– = 42.4 ± 6.2%, P = 0.01) and in hypertensive patients compared with normotensives (46.5 ± 7.7% vs 43 ± 7.2%, P = 0.02). Dry body weights and inter-HD body weight increases did not differ between hypertensive and normotensive patients nor between patients with or without LVH. ECW was correlated with SBP (r = 0.35, P < 0.01) and with left ventricular mass index (LVMig/sqm) (r = 0.49, P < 0.001). A stepwise multiple linear regression model revealed that LVMig/sqm was significantly correlated with ECW%, SBP and male gender (r = 0.65, P < 0.001).

Conclusions. LVH and hypertension are present in a majority of HD patients and they are closely correlated with one another. We found associations between fluid load, measured by BIA and expressed as ECW, and BP and LVM.

Keywords: extracellular water; haemodialysis; hypertension; left ventricular hypertrophy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Bayliss and J. Danziger
Nocturnal versus conventional haemodialysis: some current issues
Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3612 - 3617.
[Full Text] [PDF]


Home page
CJASNHome page
R. K. Patel, S. Oliver, P. B. Mark, J. R. Powell, E. P. McQuarrie, J. P. Traynor, H. J. Dargie, and A. G. Jardine
Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging
Clin. J. Am. Soc. Nephrol., September 1, 2009; 4(9): 1477 - 1483.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Agarwal, P. Alborzi, S. Satyan, and R. P. Light
Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial
Hypertension, March 1, 2009; 53(3): 500 - 507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. W Chamney, P. Wabel, U. M Moissl, M. J Muller, A. Bosy-Westphal, O. Korth, and N. J Fuller
A whole-body model to distinguish excess fluid from the hydration of major body tissues
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 80 - 89.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.